Panel Presentation at the Johns Hopkins University Bloomberg School of Public Health Symposium: Transparency at the U.S. Food and Drug Administration

January 16, 2018

View the PowerPoint Symposium Presentation.

View as PDF.

View the video of the panel presentation.

Public Citizen advocated that the Food and Drug Administration follow the lead of its European and Canadian counterpart agencies and: 1) notify the public when an application to market a new drug or new use for an already-marketed drug is rejected by the agency or withdrawn by the company; and 2) release its analyses of data submitted in support of such rejected or withdrawn applications.

See Public Citizen’s other work on FDA transparency.